Compare Nuwellis Inc (NUWE) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Western Alliance Bancorporation — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Western Alliance Bancorporation trades at $79.37 (market cap $8.72B). The key difference: Western Alliance Bancorporation is far larger — about 3488× Nuwellis Inc's market cap, and Western Alliance Bancorporation pays a 2.1% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | WAL | |
|---|---|---|
Market Cap | $2.50M | $8.72B |
Sector | Technology | Financials |
52-Week High | $164.50 | $96.08 |
52-Week Low | $0.73 | $66.70 |
Enterprise Value | -$1.21M | — |
Dividend Yield | — | 2.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Western Alliance Bancorporation (WAL) trades at $79.94, down 1.25% on the day, with a bearish technical signal despite strong fundamentals. The bank reported Q2 2026 earnings that met revenue expectations but slightly missed EPS estimates, while maintaining robust profitability with a 25.43% net income margin and 13.43% ROE. Recent developments include the launch of WA VenueX™ digital asset platform and recognition as Arizona's #1 bank by Forbes.
WAL presents a compelling value opportunity with a P/E of 9.02 and strong analyst support (79% buy ratings, $93.86 consensus target), though negative operating cash flow and bearish technical indicators warrant caution. The stock offers 17% upside to consensus target but faces headwinds from declining cash flow and mixed earnings performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
